2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

…, B Halda‐Kiss, S Hasni, PM Izmirly… - Arthritis & …, 2019 - Wiley Online Library
Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …

The clinical spectrum of autoimmune congenital heart block

P Brito-Zerón, PM Izmirly, M Ramos-Casals… - Nature Reviews …, 2015 - nature.com
Autoimmune congenital heart block (CHB) is an immune-mediated acquired disease that is
associated with the placental transference of maternal antibodies specific for Ro and La …

Mortality in systemic lupus erythematosus: an updated review

CE Fors Nieves, PM Izmirly - Current rheumatology reports, 2016 - Springer
Both systemic lupus erythematosus (SLE) and its treatments can contribute to increased
mortality rates. The focus of this review is recent studies on mortality and comorbidities during …

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody–associated cardiac manifestations of neonatal lupus

PM Izmirly, N Costedoat-Chalumeau, CN Pisoni… - Circulation, 2012 - Am Heart Assoc
Background— A recent case-control study suggested a benefit of hydroxychloroquine (HCQ)
in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies …

Prevalence of systemic lupus erythematosus in the United States: estimates from a meta‐analysis of the Centers for Disease Control and Prevention National Lupus …

PM Izmirly, H Parton, L Wang… - Arthritis & …, 2021 - Wiley Online Library
Izmirly has received consulting fees and/or honoraria from GlaxoSmithKline (less than …
Izmirly had full access to all of the data in the study and takes responsibility for the integrity …

Maternal and fetal factors associated with mortality and morbidity in a multi–racial/ethnic registry of anti-SSA/Ro–associated cardiac neonatal lupus

PM Izmirly, A Saxena, MY Kim, D Wang, SK Sahl… - Circulation, 2011 - Am Heart Assoc
Background— Cardiac manifestations of neonatal lupus include conduction disease and,
rarely, an isolated cardiomyopathy. This study was initiated to determine the mortality and …

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus …

PM Izmirly, MY Kim, C Llanos, PU Le… - Annals of the …, 2010 - ard.bmj.com
… Peter M Izmirly1, … Correspondence to Peter M Izmirly, Division of Rheumatology, Department
of Medicine, New York University (NYU) School of Medicine, TH-407, New York, NY 10016, …

Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS–CoV‐2 vaccination

PM Izmirly, MY Kim, M Samanovic… - Arthritis & …, 2022 - Wiley Online Library
… –CoV‐2 Vaccination - Izmirly - 2022 - Arthritis & Rheumatology - Wiley Online Library
Izmirly had full access to all of the data in the study and takes responsibility for the integrity …

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open‐label …

DM Friedman, C Llanos, PM Izmirly… - Arthritis & …, 2010 - Wiley Online Library
Objective The recurrence rate of anti‐SSA/Ro–associated congenital heart block (CHB) is
17%. Sustained reversal of third‐degree block has never been achieved. Based on potential …

The incidence and prevalence of systemic lupus erythematosus in New York County (Manhattan), New York: the Manhattan lupus surveillance program

PM Izmirly, I Wan, S Sahl, JP Buyon… - Arthritis & …, 2017 - Wiley Online Library
IZMIRLY ET AL … IZMIRLY ET AL … Izmirly had full access to all of the data in the study
and takes responsibility for the integrity of the data and the accuracy of the data analysis. …